0001209191-19-025841.txt : 20190424 0001209191-19-025841.hdr.sgml : 20190424 20190424202556 ACCESSION NUMBER: 0001209191-19-025841 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190422 FILED AS OF DATE: 20190424 DATE AS OF CHANGE: 20190424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barrett John A CENTRAL INDEX KEY: 0001388395 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36304 FILM NUMBER: 19765056 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE, SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20111019 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-22 0 0001533040 Phio Pharmaceuticals Corp. PHIO 0001388395 Barrett John A C/O PHIO PHARMACEUTICALS CORP. 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752 0 1 0 0 Chief Development Officer Common stock, $0.0001 par value 2019-04-22 4 A 0 222991 0.00 A 222991 D This amount is comprised entirely of Restricted Stock Units which shall vest in equal installments over four years, with the first installment on April 22, 2020 and the last installment on April 22, 2023, subject to continued employment with the Company on the applicable vesting date. Caitlin Kontulis, attorney-in-fact 2019-04-24